ALK Inhibition: Science and Early Clinical Experience, by Dr. Ben Solomon (audio)

GRACEcast Lung Cancer Audio

English - October 31, 2011 06:49 - 17 minutes - 16.1 MB - ★★★★★ - 1 rating
Science Health & Fitness Medicine grace cancergrace gracecast lung cancer nsclc chemotherapy chemo radiation non Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Q and A Session with Dr. Rogerio Lilenbaum, on Managing Lung Cancer in Elderly Patients (audio)

Next Episode: ALK Inhibition: Who to Screen, and Additional Options for ALK-Positive Patients, by Dr. Ross Camidge (audio)

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.